Search results
Results from the WOW.Com Content Network
Moderna was founded in 2010 by Derrick Rossi, Timothy A. Springer, Kenneth R. Chien, Robert S. Langer, and Noubar Afeyan. [9] Stéphane Bancel , the current CEO, was appointed as CEO in 2011. [ 6 ] [ 10 ] Between 2011 and 2017, Moderna raised $2 billion in venture capital funding.
Noubar Afeyan (Western Armenian: Նուպար Աֆէեան; born in 1962) is an American-Canadian entrepreneur, inventor, and philanthropist. [1] [2] He is best known for co-founding the biotechnology company Moderna, through his venture capital firm, Flagship Pioneering, and for co-founding humanitarian projects such as Aurora Prize and The Future Armenian.
Moderna was founded in 2010, based on discovery that pluripotent stem cells can be transformed and reprogrammed. [ 10 ] [ 11 ] Time magazine cited this pluripotent discovery as one of the top ten medical breakthroughs of the year.
Moderna's (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot.. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET Monday after it updated ...
For premium support please call: 800-290-4726 more ways to reach us
After a solid run since starting at the sub-$20 levels at the start of the year, Moderna (NASDAQ:MRNA) continues to attract plenty of buying and selling activity. Ultimately, the direction of MRNA ...
The Moderna news followed preliminary results from the Pfizer-BioNTech vaccine candidate, BNT162b2, with Moderna demonstrating similar efficacy, but requiring storage at the temperature of a standard medical refrigerator of 2–8 °C (36–46 °F) for up to thirty days or −20 °C (−4 °F) for up to four months, whereas the Pfizer-BioNTech ...
Moderna plans to cut annual research and development (R&D) spending by more than $1 billion starting in 2027 and discontinue five programs -- and it forecast that it would break even in 2028 ...